Reporting owner · CIK 0002010224
Lantheus Alpha Therapy, LLC
SEC Form 4 history across 1 companies, 5 transactions and 3 filings.
10%Perspective Therapeutics, Inc.
Open-market transaction mix0% buys0 buys · 5 sales
Available history · Aug 31, 2026 – Sep 04, 2026
Latest insider transactions
Form 4 filings from available history.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
CATXPerspective Therapeutics, Inc. | Lantheus Alpha Therapy, LLC10% | S · saleSEC filing ↗ | -$526kView disclosure → | |
CATXPerspective Therapeutics, Inc. | Lantheus Alpha Therapy, LLC10% | S · saleSEC filing ↗ | -$250kView disclosure → | |
CATXPerspective Therapeutics, Inc. | Lantheus Alpha Therapy, LLC10% | S · saleSEC filing ↗ | -$131kView disclosure → | |
CATXPerspective Therapeutics, Inc. | Lantheus Alpha Therapy, LLC10% | S · saleSEC filing ↗ | -$111kView disclosure → | |
CATXPerspective Therapeutics, Inc. | Lantheus Alpha Therapy, LLC10% | S · saleSEC filing ↗ | -$245kView disclosure → |
Latest Form 4 facts
Quick context from source filings
Latest open-market transaction
sale at Perspective Therapeutics, Inc. on Sep 04, 2026 valued at $526,051.
Review SEC filingLatest buy
No open-market insider purchase is available.
Latest sale
sale at Perspective Therapeutics, Inc. on Sep 04, 2026 valued at $526,051.
Review SEC filingMonthly open-market activity
Last 2 reported months · purchases and sales
View exact monthly values
| Month | Purchases | Sales | Buy value | Sale value | Net value |
|---|---|---|---|---|---|
| Aug 2026 | 0 | 1 | $0.00 | $245,609.74 | -$245,609.74 |
| Sep 2026 | 0 | 4 | $0.00 | $1,019,740.61 | -$1,019,740.61 |
Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.
Ownership and transaction size
Ownership and ticket size
Average P/S size$253.1K
Median P/S size$245.6K
Direct5
Indirect0
Sep 04, 2026sale
Filing-only signals
Deterministic matches in this insider's history
No filing-only signal badges matched this history.
Associated companies
Companies in the disclosed reporting history
Open-market buy performance
90-day forward return on this insider's open-market purchases
No open-market purchases in available history
A 90-day purchase return requires an open-market buy. No eligible purchases are recorded in this history.
Disclosed ownership
How reported shareholdings evolved
Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.
5 observations · Aug 31, 2026 – Sep 4, 2026. Window ends at the latest available report, not today.
Selected observation · Sep 4, 202611,273,364 shares reported
Inspect transaction View exact observations and source transactions
| Transaction date | Shares held after | Filed | Source |
|---|---|---|---|
| Aug 31, 2026 | 11,599,194 | Sep 4, 2026 | View transaction |
| Sep 1, 2026 | 11,563,425 | Sep 4, 2026 | View transaction |
| Sep 2, 2026 | 11,521,296 | Sep 4, 2026 | View transaction |
| Sep 3, 2026 | 11,440,513 | Sep 8, 2026 | View transaction |
| Sep 4, 2026 | 11,273,364 | Sep 8, 2026 | View transaction |
Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.
Lantheus Alpha Therapy, LLC Insider Activity FAQ
SEC Form 4 context
Who is Lantheus Alpha Therapy, LLC?
Lantheus Alpha Therapy, LLC is a reporting owner in SEC Form 4 filings with reporting owner CIK 0002010224.
Which companies has Lantheus Alpha Therapy, LLC reported transactions for?
Perspective Therapeutics, Inc.
When was Lantheus Alpha Therapy, LLC's latest insider buy?
No open-market insider purchase is available for this period.
When was Lantheus Alpha Therapy, LLC's latest insider sale?
sale at Perspective Therapeutics, Inc. on Sep 04, 2026 valued at $526,051.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.